Ann: Acrux's fourth generic dossier accepted by FDA for review, page-6

it is disappointing that when we get a piece of genuine good news for a change (dossier accepted for review), some prick decides to sell off and take the price down.

There is a lot of pimple faced nerds about these days (I used to be one of them - now just a nerd) that want a method of cleaning their face . Surely that is a very good business.

I am exasperated and pissed off.

Perhaps we should promote all the bad news to try to get an sp increase - clearly good news is not the answer.

At this stage I would piss on a spark plug if I thought that such an action would generate some interest in ACR shares. But of course that will not work either.